[
    [
        {
            "time": "2018-03-15",
            "original_text": "Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Dips",
                    "Broader Markets"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-10",
            "original_text": "Drug Stocks Slide as Never-Ending Political Worry Gathers Steam",
            "features": {
                "keywords": [
                    "Drug Stocks",
                    "Slide",
                    "Political Worry"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Drug Stocks Slide as Never-Ending Political Worry Gathers Steam",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-05-02",
            "original_text": "After losing out on big prospect, O'Neill's Discovery Labs takes on cell-gene therapy manufacturing",
            "features": {
                "keywords": [
                    "Discovery Labs",
                    "cell-gene therapy",
                    "manufacturing"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "After losing out on big prospect, O'Neill's Discovery Labs takes on cell-gene therapy manufacturing",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-06-18",
            "original_text": "J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children",
            "features": {
                "keywords": [
                    "J&J",
                    "Stelara",
                    "EU Nod",
                    "Plaque Psoriasis"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-22",
            "original_text": "Anat Hakim to join Lilly as General Counsel",
            "features": {
                "keywords": [
                    "Anat Hakim",
                    "Lilly",
                    "General Counsel"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Anat Hakim to join Lilly as General Counsel",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        }
    ]
]